| 1 |
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase |
|
| | Ismail Celik,Meryem Erol,Zekeriya Duzgun | | | Molecular Diversity. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Retrospective analysis of severe COVID-19 pneumonia patients treated with lopinavir/ritonavir: A comparison with survivor and non-survivor patients |
|
| | Omer Ayten,Bengu Saylan | | | Southern African Journal of Infectious Diseases. 2020; 35(1) | | | [Pubmed] [Google Scholar] [DOI] | |
|
